Skip to main content
42257 Suchergebnisse für:

G-CSF 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. 28.03.2024 | Online First

    Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022

    Novel androgen receptor signal inhibitors (ARAT) and taxane-based chemotherapy are crucial agents for treating metastatic castration-resistant prostate cancer (mCRPC). Docetaxel (DTX) is commonly used as a primary chemotherapy, and cabazitaxel …

  2. 05.04.2024 | Online First

    Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology

    The digestive system is a major source of cancer, with colorectal cancer being the most commonly diagnosed type in Japan in the year 2019 [ 1 ]. The development of cancer chemotherapy has significantly improved the prognosis of cancer patients; …

  3. 25.03.2024 | Online First

    Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022

    Prophylactic pegylated granulocyte colony-stimulating factor (G-CSF) during cancer chemotherapy is typically administered on or after the day following the completion of chemotherapy (Days 2, 3, 4, or 5). No consensus has been established on which …

  4. 14.02.2024 | OriginalPaper

    Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022

    Lung cancer is the predominant cause of mortality in many countries [ 1 ] and presents a significant public health challenge. Most lung cancer cases are diagnosed at an advanced stage, necessitating comprehensive and systematic pharmacotherapy as …

  5. Open Access 18.03.2024 | Online First

    Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology

    Although granulocyte colony-stimulating factor (G-CSF) reduces the incidence, duration, and severity of neutropenia, its prophylactic use for acute myeloid leukemia (AML) remains controversial due to a theoretically increased risk of relapse. The …

  6. 19.12.2023 | OriginalPaper

    GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease

    Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with the development of a network of abnormal vessels. Immune inflammation is associated with the occurrence and development of MMD. However, the mechanisms underlying the …

  7. 29.09.2023 | OriginalPaper

    “Sealing the Gap” : CSF Leakage Demystified-A Comprehensive Analysis of our Experience in CSF Rhinorrhea Management

    CSF (Cerebro Spinal Fluid) rhinorrhoea occurs when the fluid leaks from subarachnoid space into the nasal cavity. The study aims to find out the prevalence and demographic distribution of CSF leak and to describe the site of the CSF leak along …

  8. 20.02.2024 | Online First

    Disseminated nocardiosis and anti-GM-CSF antibodies

    Infections that are unusually severe or caused by opportunistic pathogens are a hallmark of primary immunodeficiency (PID). Anti-cytokine autoantibodies (ACA) are an emerging cause of acquired immunodeficiency mimicking PID. Nocardia spp. are …

  9. 22.03.2024 | Online First

    Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022

    Granulocyte colony-stimulating factor (G-CSF) decreases the incidence, duration, and severity of febrile neutropenia (FN); however, dose reduction or withdrawal is often preferred in the management of adverse events in the treatment of urothelial …

  10. Open Access 01.12.2024 | OriginalPaper

    The genomic alterations in glioblastoma influence the levels of CSF metabolites

    Cerebrospinal fluid (CSF) analysis is underutilized in patients with glioblastoma (GBM), partly due to a lack of studies demonstrating the clinical utility of CSF biomarkers. While some studies show the utility of CSF cell-free DNA analysis …

  11. Open Access 01.12.2024 | Letter

    Putative novel CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort

  12. 24.01.2024 | OriginalPaper

    MRI-based Machine Learning Radiomics Can Predict CSF1R Expression Level and Prognosis in High-grade Gliomas

    The purpose of this study is to predict the mRNA expression of CSF1R in HGG non-invasively using MRI (magnetic resonance imaging) omics technology and to evaluate the correlation between the established radiomics model and prognosis. We …

  13. 30.12.2023 | OriginalPaper

    Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer

    Brain metastases most commonly arise in patients with lung cancer, breast cancer, and melanoma. Brain metastases are generally associated with poor quality of life and pose distinctive clinical challenges [ 1 , 2 ]. Precision medicine and the use …

  14. 19.12.2023 | OriginalPaper

    Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation

    Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a genetically and clinically heterogeneous disorder with predominant neurological involvement [ 1 , 2 ]. The disease is caused by a genetic mutation in …

  15. 28.09.2023 | OriginalPaper

    Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer’s disease: racial differences

    Alzheimer’s disease (AD) is the most common form of dementia, characterized by progressive loss of memory and cognitive functions due to continuous neuron damage and resultant increases in affected areas of the brain [ 1 ], which refers to the …

  16. Open Access 01.12.2023 | OriginalPaper

    CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice

    Graft-versus-host disease (GVHD) is a serious complication of otherwise curative allogeneic haematopoietic stem cell transplants. Chronic GVHD induces pathological changes in peripheral organs as well as the brain and is a frequent cause of late …

  17. 20.04.2023 | OriginalPaper

    Germline CSF3R, RUNX1 and ETV6 Pathogenic Variants in a Case of Atypical Chronic Myeloid Leukemia: Individual to Familial Unravelling by Next Generation Sequencing

    Myelodysplastic syndrome/Myeloproliferative neoplasm (MDS/MPN) overlap syndromes are recently identified entities that have been quite difficult to define due to overlapping morphological features and absence of a specific molecular abnormality.

  18. Open Access 26.10.2022 | Beinulkus | OriginalPaper

    Lokale Therapie von venösen Ulzera mit niedrig dosiertem rekombinantem, humanem „granulocyte-macrophage colony-stimulating factor“ (rhu GM-CSF), 10 Jahre Nachbeobachtung

    Chronisch venöse Ulzera betreffen 1 % der erwachsenen Bevölkerung in industrialisierten Ländern. Die Abheilung dieser Geschwüre ist verzögert, und Rezidive sind häufig. Die dadurch entstehenden Kosten im Gesundheitssystem der entwickelten Länder …

  19. 20.06.2022 | Zytostatische Therapie | ContinuingEducation

    G-CSF zur Prophylaxe der Neutropenie und der febrilen Neutropenie, Anämie bei Krebserkrankung

    Supportivtherapieleitlinien, Teil 1

    Infektionen bei neutropenischen Patienten nach Chemotherapie manifestieren sich meistens durch Fieber (febrile Neutropenie, FN). Zu den wichtigsten Determinanten des FN-Risikos gehören der Chemotherapietyp, die Dosisintensität und …

  20. Open Access 05.07.2023 | OriginalPaper

    Genetic Architecture and Functional Implications of the CSF-Contacting Nucleus

    We previously identified a unique nucleus, the cerebrospinal fluid (CSF)-contacting nucleus. This study aims to understand its gene architecture and preliminarily suggest its functions. The results showed that there were about 19,666 genes in this …

Suchergebnisse filtern:

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.